Cross-Site Scripting Vulnerability in IBM WebSphere Portal
CVE-2017-1761

6.1MEDIUM

Key Information:

Vendor

IBM
Status
Websphere Portal
Vendor
CVE Published:
9 February 2018

What is CVE-2017-1761?

The WebSphere Portal from IBM versions 7.0, 8.0, 8.5, and 9.0 contains a Cross-Site Scripting vulnerability that permits an attacker to inject malicious JavaScript into the Web UI. This flaw can lead to unauthorized execution of scripts, potentially resulting in the leakage of sensitive user credentials during active sessions. Such attacks exploit trust relationships by compromising a trusted context, making it crucial for organizations using these versions of WebSphere Portal to implement security measures to mitigate risks. For more information, visit IBM's support pages.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

WebSphere Portal 7.0

WebSphere Portal 8.0

WebSphere Portal 8.5

References

https://exchange.xforce.ibmcloud.com/vulnerabilities/136005
x_refsource_MISC
http://www.ibm.com/support/docview.wss?uid=swg22012416
x_refsource_CONFIRM
http://www.securitytracker.com/id/1040333
vdb-entryx_refsource_SECTRACK

CVSS V3.1

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.